Assessment and recommendation
HTA Network |
|
HTA is an important part of evidence-based health decision making in most EU countries. To enhance cooperation between countries, the Commission has set up a permanent, voluntary HTA network in Europe. The network aims to facilitate efficient use of HTA resources in Europe, create a sustainable system of HTA knowledge sharing, promote good practice in HTA methods and processes.The Directorate-General for Health represents France in the HTA Network. HAS participates in support of the Directorate-General for Health in the work of the HTA Network. Learn more: |
|
HTAi (Health Technology Assessment International) |
|
HTAi "Health Technology Assessment International" is a scientific and professional society for all those who produce or use health technology assessments. This structure brings together all stakeholders (researchers, assessment agencies, policy makers, manufacturers, health service providers, patient representatives) and all fields concerned (medicine, public health, economics, social sciences, health services research). It is an international network that seeks to neutrally and independently encourage collaboration and sharing of information and expertise. Since its founding in 2003, this network has grown quickly, with 59 countries represented on six continents. HTAi has signed agreements with the WHO, the International Network of Agencies for Health Technology Assessment (INAHTA) and an agreement is being signed with the iHEA (International Health Economics Association). HAS is a member of HTAi. HAS regularly and actively participates in the HTAi annual meeting (plenary session, organisation and participation in panels, oral presentations, posters).Dr F. Meyer (advisor to HAS’s Chair of the Board, in charge of international affairs) has been a member of the HTAi Board of Directors since 2011. (add link to the HTAi Board) HAS is also a member of INAHTA. (logo to be added) |
|
EUSAHN (European Science Advice Network for Health) |
|
EUSANH is a network of national agencies and science advisory bodies on healthcare matters that focuses its work on scientific cooperation (information and expertise) with a unifying goal (establishment of transnational committees, transnational approval process for reports, coordination of work programmes). HAS is a member of the EUSAHN network and was a member of the Scientific Council for the project EuSAHN–ISA (2009-2011) as part of the 7th Framework Programme for Research of the European Commission. Learn more: |
|
GIN (Guidelines International Network) |
|
This network, founded in 2002, brings together 100 organisations in 48 countries. It supports and promotes the development of health guidelines, and their adaptation, distribution and implementation. The GIN International Library, regularly updated, lists more than 6500 guidelines and practical tools. HAS was represented on the GIN board and regularly participates in the GIN annual meeting, the only international congress dedicated to good practice guidelines. HAS is the chair of the Accelerated Guideline Development Working Group) and actively participated in the Evidence Tables Working Group (now the GIN Tech Working Group). Learn more: - attachment or link to the publication Mlika Cabanne et al, on the behalf of G.I.N network, Qual saf Health care, 2011 Feb; 20(2): 141-145.dol:10.1136/bmjqs.2010.040923 www.g-i-n.net/working-groups/accelerated-guideline-development |
|
ISPOR (International Society for Pharmacoeconomics and Outcomes Research) |
|
ISPOR (International Society for Pharmacoeconomics and Outcomes Research) is an international society represented in 92 countries that aims "to increase the cost-effectiveness, real-life efficacy, and fairness and appropriateness of the allocation of health care resources to improve health". HAS regularly participates in the ISPOR Annual Meeting. Learn more: |
Accreditation and certification